Phase II clinical protocol for the treatment of patients with previously untreated chronic lymphocytic leukaemia
Phase of Trial: Phase II
Latest Information Update: 12 Feb 2016
At a glance
- Drugs Cyclophosphamide (Primary) ; Fludarabine (Primary) ; Rituximab (Primary)
- Indications Chronic lymphocytic leukaemia
- Focus Adverse reactions; Therapeutic Use
- 01 Jan 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 07 Jul 2012 Planned end date changed from 1 Jun 2011 to 1 Jul 2013 as reported by ClinicalTrials.gov.
- 28 Apr 2011 Planned End Date changed from 1 Jun 2009 to 1 Jun 2011 as reported by ClinicalTrials.gov.